DeepCurrents Investment Group LLC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AB6. A total of 27 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DeepCurrents Investment Group LLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$70,957,707
-2.5%
76,898,000
-3.8%
2.76%
-2.2%
Q4 2022$72,811,602
+1.0%
79,898,000
+1.3%
2.83%
+2.2%
Q3 2022$72,089,000
+3.2%
78,898,0000.0%2.77%
-0.8%
Q2 2022$69,839,000
-3.6%
78,898,000
-1.9%
2.79%
+23.6%
Q1 2022$72,441,000
+11.5%
80,398,000
+11.7%
2.26%
+11.7%
Q4 2021$64,996,000
+3.3%
72,004,000
+3.6%
2.02%
+7.5%
Q3 2021$62,930,000
-12.0%
69,504,000
-9.9%
1.88%
-12.3%
Q2 2021$71,504,000
-5.7%
77,144,000
-3.1%
2.14%
-17.9%
Q1 2021$75,861,000
-6.4%
79,644,0000.0%2.61%
+22.4%
Q4 2020$81,053,00079,644,0002.13%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
STEELHEAD PARTNERS LLC 65,391,000$67,089,0004.52%
DeepCurrents Investment Group LLC 79,644,000$81,053,0002.13%
ADVENT CAPITAL MANAGEMENT /DE/ 76,017,000$78,229,0001.67%
Opti Capital Management, LP 12,900,000$13,223,0001.47%
CAMDEN ASSET MANAGEMENT L P /CA 37,474,000$38,245,0001.32%
Soleus Capital Management, L.P. 8,500,000$8,675,0001.14%
TENOR CAPITAL MANAGEMENT Co., L.P. 33,000,000$33,861,0000.95%
AQR Arbitrage LLC 21,200,000$21,742,0000.76%
III Capital Management 4,600,000$4,734,0000.60%
SHENKMAN CAPITAL MANAGEMENT INC 4,621,000$4,774,0000.50%
View complete list of IONIS PHARMACEUTICALS INC shareholders